Karolinska Development (KDventures) aims to invest in innovative life science companies. The firm believes investments should be meaningful and focuses on creating returns by supporting the development of promising therapeutics and medical technologies. KDventures provides investors the opportunity to invest in the future of pharmaceutical and medtech companies without necessarily being a specialist in the field and diversifying their risk. The firm's investment model focuses on identifying and nurturing early-stage life science companies with the potential for significant growth and impact. They leverage their expertise and network within the life science ecosystem to support these companies through various stages of development, from preclinical to clinical trials and eventual commercialization. They possess unique competence in the life science field. KDventures aims to bridge the gap between promising research and successful commercialization, contributing to advancements in healthcare and generating financial returns for their investors through exits.
Bevorzugte Reifephase für die erste Finanzierung.
Life Science, Pharmaceuticals, Medtech
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...